INSULET CORPORATION (PODD) Cash and securities
- Total cash · latest quarter (USD): Value $857.10M; Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2021-09-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2021-09-30..
Cash and securities
Overview →Financial period ending 2021-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | $857.10M | Cash and cash equivalents plus current marketable securities. Period ending 2021-09-30. $856.60M + $500.00K ≈ $857.10M |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2021-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 856.60M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 500.00K USD | Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Cash and current securities | 857.10M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2021-09-30 | $857.10M | (m) | $856.60M | $500.00K | (m) |
| 2021-06-30 | $872.10M | (m) | $854.60M | $17.50M | (m) |
| 2021-03-31 | $850.20M | (m) | $820.70M | $29.50M | (m) |
| 2020-12-31 | $947.60M | (m) | $907.20M | $40.40M | (m) |
| 2020-09-30 | $896.70M | (m) | $838.10M | $58.60M | (m) |
| 2020-06-30 | $844.40M | (m) | $779.10M | $65.30M | (m) |
| 2020-03-31 | $321.60M | (m) | $201.40M | $120.20M | (m) |
| 2019-12-31 | $376.10M | (m) | $213.70M | $162.40M | (m) |
| 2019-09-30 | $605.50M | (m) | $419.88M | $185.62M | (m) |
| 2019-06-30 | $309.75M | (m) | $119.87M | $189.88M | (m) |
| 2019-03-31 | $316.37M | (m) | $129.25M | $187.12M | (m) |
| 2018-12-31 | $288.95M | (m) | $113.91M | $175.04M | (m) |
| 2018-09-30 | $289.84M | (m) | $126.56M | $163.28M | (m) |
| 2018-06-30 | $299.79M | (m) | $136.25M | $163.55M | (m) |
| 2018-03-31 | $352.00M | (m) | $203.15M | $148.85M | (m) |
| 2017-12-31 | $440.06M | (m) | $272.58M | $167.48M | (m) |
| 2017-09-30 | $275.76M | (m) | $102.23M | $173.52M | (m) |
| 2017-06-30 | $258.61M | (m) | $73.49M | $185.12M | (m) |
| 2017-03-31 | $254.03M | (m) | $76.04M | $177.99M | (m) |
| 2016-12-31 | $298.57M | (m) | $137.17M | $161.40M | (m) |
| 2016-09-30 | $282.69M | (m) | $215.40M | $67.29M | (m) |
| 2016-06-30 | $111.27M | (m) | $75.66M | $35.60M | (m) |
| 2016-03-31 | (m) | (m) | $111.64M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $122.67M | (m) | (m) |
| 2015-09-30 | (m) | (m) | $145.47M | (m) | (m) |
| 2015-06-30 | (m) | (m) | $145.14M | (m) | (m) |
| 2015-03-31 | (m) | (m) | $145.61M | (m) | (m) |
| 2014-12-31 | (m) | (m) | $151.19M | (m) | (m) |
| 2014-09-30 | (m) | (m) | $146.37M | (m) | (m) |
| 2014-06-30 | (m) | (m) | $175.54M | (m) | (m) |
| 2014-03-31 | (m) | (m) | $145.61M | (m) | (m) |
| 2013-12-31 | (m) | (m) | $149.73M | (m) | (m) |
| 2013-09-30 | (m) | (m) | $153.91M | (m) | (m) |
| 2013-06-30 | (m) | (m) | $150.94M | (m) | (m) |
| 2013-03-31 | (m) | (m) | $148.06M | (m) | (m) |
| 2012-12-31 | (m) | (m) | $57.29M | (m) | (m) |
| 2012-09-30 | (m) | (m) | $63.44M | (m) | (m) |
| 2012-06-30 | (m) | (m) | $70.14M | (m) | (m) |
| 2012-03-31 | (m) | (m) | $83.01M | (m) | (m) |
| 2011-12-31 | (m) | (m) | $93.95M | (m) | (m) |
| 2011-09-30 | (m) | (m) | $103.81M | (m) | (m) |
| 2011-06-30 | (m) | (m) | $106.75M | (m) | (m) |
| 2011-03-31 | (m) | (m) | $104.49M | (m) | (m) |
| 2010-12-31 | (m) | (m) | $113.27M | (m) | (m) |
| 2010-09-30 | (m) | (m) | $103.92M | (m) | (m) |
| 2010-06-30 | (m) | (m) | $118.07M | (m) | (m) |
| 2009-12-31 | (m) | (m) | $128.00M | (m) | (m) |
| 2008-12-31 | (m) | (m) | $56.66M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |